Introduction Febrile neutropenia represents one of the most common treatment-associated
complications in the management of acute myeloid leukemia (AML) and is considered an …

Reducing avoidable antimicrobial exposure to pediatric patients with cancer is achievable
and necessary to promote optimal short-and long-term outcomes. Multiple evidence-based …

Background Fever in neutropenia (FN) is a potentially life-threatening complication of
chemotherapy in pediatric cancer patients. The current standard of care at most institutions …

Purpose Investigation of the current practice of diagnostics and treatment in pediatric cancer
patients with febrile neutropenia. Methods On behalf of the German Society for Pediatric …

Background The timing and necessity of repeated blood cultures (BCs) in children with
cancer and febrile neutropenia (FN) are unknown. We evaluated the diagnostic yield of BCs …

Febrile neutropenia (FN) is a common condition in children receiving chemotherapy. Our
goal in this study was to develop a model for predicting blood stream infection (BSI) and …

Background: We evaluated the clinical significance of repeat blood cultures in persistent and
recurrent fever during neutropenia in adult acute myeloid leukaemia (AML) and …

Background: The approach to recurrent febrile neutropenia (FN) in children with cancer has
not been sufficiently addressed and was cited as a research gap in the International …

Clear recommendations are needed on when repeat blood cultures (BCxs) in hospitalized
children with cancer should be obtained. We reviewed all BCx obtained on the Hematology …

Methods: We visualized preintervention rates of blood cultures drawn on pediatric oncology
inpatients using a control chart. Following the introduction of the algorithm to our division, an …